Malignant neoplasm of unspecified site of left female breast
ICD-10 C50.912 is a billable code used to indicate a diagnosis of malignant neoplasm of unspecified site of left female breast.
C50.912 refers to a malignant neoplasm located in the left female breast, where the specific site of the tumor is not specified. Breast cancer is a heterogeneous disease characterized by the uncontrolled growth of breast cells. It can present in various forms, including invasive ductal carcinoma, invasive lobular carcinoma, and others. Hormone receptor status (estrogen and progesterone receptors) and HER2 status are critical in determining the tumor's biology and guiding treatment. Estrogen receptor-positive (ER+) tumors may respond to hormone therapies, while HER2-positive tumors may benefit from targeted therapies like trastuzumab. Staging of breast cancer is crucial for treatment planning and prognosis, typically classified from Stage 0 (in situ) to Stage IV (metastatic disease). Treatment protocols may include surgery, radiation therapy, chemotherapy, and targeted therapies, depending on the stage and receptor status of the cancer.
Detailed pathology reports, imaging studies, and treatment plans.
Initial diagnosis, treatment planning, and follow-up care.
Ensure all tumor characteristics and receptor statuses are documented.
Clear imaging reports indicating findings related to breast lesions.
Diagnostic imaging for breast masses and follow-up imaging.
Link imaging findings to the specific diagnosis for accurate coding.
Used when a patient undergoes a total mastectomy for left breast cancer.
Operative reports must detail the procedure and confirm malignancy.
Oncology specialists must ensure accurate coding based on surgical findings.
C50.912 indicates a malignant neoplasm of the left female breast where the specific site is not specified, requiring careful documentation of the tumor's characteristics and treatment.
